Adeyinka Taiwo, MBBS, MSc, FRCP, clinical assistant professor in Endocrinology and Metabolism, has published novel research laying the foundation for continued study of T1D comorbidity with the nation’s most common chronic liver disease.

Cancer care at UI Health Care is ranked ranked among the nation’s top 50, and Gastroenterology and Pulmonology are among the top 10%, according to the 2025-2026 rankings published by U.S. News & World Report.

The American Heart ASsociation's "Get with the Guidelines" program recently recognized University of Iowa Health Care Emergency Response Team (ERT) Director Paul Nassar, MD, MPH, and his Code Blue Team with Silver Recognition for excellence in CPR quality.

Iowa City VA Staff Physician and Clinical Assistant Professor in Hospital Medicine Matthew Soltys, MD, MME, was recognized for his local and national commitment to engaging physicians and medical trainees in robust quality improvement (QI) and patient safety education.

University of Iowa researchers have received a significant grant to study primary ciliary dyskinesia, a rare airway disease, aiming to advance understanding and treatment options for affected patients. This funding will support innovative research efforts to improve patient outcomes.

Effective July 1, the Division of Nephrology and Hypertension will be led by Lisa Antes, MD, and Sarat Kuppachi, MD, as co-interim division directors.

University of Iowa researchers, including Terry Wahls, reveal the importance of our gut microbiome to health and disease.

The Department of Internal Medicine is pleased to announce that Justin Smock, MD, clinical professor of internal medicine, will become interim director for the Division of General Internal Medicine (GIM), effective September 1.

Stephen McGowan, MD, Professor Emeritus of Medicine in the Division of Pulmonary, Critical Care, and Occupational Medicine, was formally presented with the 5th annual DiBona Academics in Service of ICVA Veterans Award.

The Chaurasia Lab, led by Bhagirath Chaurasia, MSc, PhD, assistant professor in the Division of Endocrinology & Metabolism, has continued to explore emerging targets to reduce obesity and treat metabolic conditions. Their recent publication, “Ceramide-induced FGF13 impairs systemic metabolic health,” appears in Cell Metabolism and contributes to the group’s history of groundbreaking research in the field.